Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Biogen and Denali sign Parkinson’s drug deal worth $2bn

pharmaceutical-technologyAugust 10, 2020

Tag: Biogen , Denali , Parkinson , DNL151 , LRRK2

PharmaSources Customer Service